Bernd Clement
#151,331
Most Influential Person Now
Researcher
Bernd Clement's AcademicInfluence.com Rankings
Bernd Clementcomputer-science Degrees
Computer Science
#11742
World Rank
#12489
Historical Rank
Machine Learning
#5401
World Rank
#5472
Historical Rank
Artificial Intelligence
#5825
World Rank
#5914
Historical Rank
Database
#8831
World Rank
#9275
Historical Rank
Download Badge
Computer Science
Why Is Bernd Clement Influential?
(Suggest an Edit or Addition)According to Wikipedia, Bernd Clement is a German pharmacist and chemist. He is mostly known for his research in biotransformation and prodrugs as well as his engagement in many German and international committees and scientific organisations. His most noticeable achievement was the discovery of the mARC enzyme.
Bernd Clement's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Lessons learned from marketed and investigational prodrugs. (2004) (354)
- The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3,-a] quinoxalin-1-one is a nonselective heme protein inhibitor of nitric oxide synthase and other cytochrome P-450 enzymes involved in nitric oxide donor bioactivation. (1999) (163)
- Identification of the Missing Component in the Mitochondrial Benzamidoxime Prodrug-converting System as a Novel Molybdenum Enzyme* (2006) (139)
- REDUCTION OF N-HYDROXYLATED COMPOUNDS: AMIDOXIMES (N-HYDROXYAMIDINES) AS PRO-DRUGS OF AMIDINES (2002) (113)
- The fourth molybdenum containing enzyme mARC: cloning and involvement in the activation of N-hydroxylated prodrugs. (2008) (89)
- Biochemical and Spectroscopic Characterization of the Human Mitochondrial Amidoxime Reducing Components hmARC-1 and hmARC-2 Suggests the Existence of a New Molybdenum Enzyme Family in Eukaryotes* (2010) (85)
- Synthesis and biological evaluation of 11-substituted 6-aminobenzo[c]phenanthridine derivatives, a new class of antitumor agents. (2005) (85)
- Characterization of in vitro biotransformation of new, orally active, direct thrombin inhibitor ximelagatran, an amidoxime and ester prodrug. (2003) (80)
- Microsomal cytochrome P450 dependent oxidation of N-hydroxyguanidines, amidoximes, and ketoximes: mechanism of the oxidative cleavage of their C=N(OH) bond with formation of nitrogen oxides. (1998) (79)
- In vivo spin trapping of glyceryl trinitrate-derived nitric oxide in rabbit blood vessels and organs. (1995) (78)
- Reduction of N(ω)-hydroxy-L-arginine by the mitochondrial amidoxime reducing component (mARC). (2011) (73)
- The Pharmacokinetics of Fumaric Acid Esters Reveal Their In Vivo Effects. (2018) (70)
- Detection of metabolites of fumaric acid esters in human urine: implications for their mode of action. (2009) (68)
- Pharmacokinetics of anti-psoriatic fumaric acid esters in psoriasis patients (2010) (67)
- Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A. (2014) (65)
- Cytochrome P450 dependent N-hydroxylation of a guanidine (debrisoquine), microsomal catalysed reduction and further oxidation of the N-hydroxy-guanidine metabolite to the urea derivative. Similarity with the oxidation of arginine to citrulline and nitric oxide. (1993) (57)
- The fourth mammalian molybdenum enzyme mARC: current state of research (2011) (54)
- Detection of fumarate–glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism (2013) (53)
- On the mechanism of nitric oxide formation upon oxidative cleavage of C = N(OH) bonds by NO-synthases and cytochromes P450. (1995) (52)
- Isolation and Characterization of the Protein Components of the Liver Microsomal O2-insensitive NADH-Benzamidoxime Reductase* (1997) (49)
- The Involvement of Mitochondrial Amidoxime Reducing Components 1 and 2 and Mitochondrial Cytochrome b5 in N-Reductive Metabolism in Human Cells* (2013) (48)
- The mammalian molybdenum enzymes of mARC (2015) (48)
- N-hydroxylation of the antiprotozoal drug pentamidine catalyzed by rabbit liver cytochrome P-450 2C3 or human liver microsomes, microsomal retroreduction, and further oxidative transformation of the formed amidoximes. Possible relationship to the biological oxidation of arginine to NG-hydroxyarginin (1994) (48)
- A two-step synthesis of cytostatically active benzo[c]phenanthridine derivatives. (2005) (48)
- Microsomal catalyzed N-hydroxylation of guanabenz and reduction of the N-hydroxylated metabolite: characterization of the two reactions and genotoxic potential of guanoxabenz. (1996) (45)
- The mitochondrial Amidoxime Reducing Component (mARC) is involved in detoxification of N-hydroxylated base analogues. (2012) (44)
- HEPATIC, EXTRAHEPATIC, MICROSOMAL, AND MITOCHONDRIAL ACTIVATION OF THE N-HYDROXYLATED PRODRUGS BENZAMIDOXIME, GUANOXABENZ, AND RO 48-3656 ([[1-[(2S)-2-[[4-[(HYDROXYAMINO)IMINOMETHYL]BENZOYL]AMINO]-1-OXOPROPYL]-4-PIPERIDINYL]OXY]-ACETIC ACID) (2005) (40)
- Modulating the NO generating system from a medicinal chemistry perspective: current trends and therapeutic options in cardiovascular disease. (2010) (39)
- Reduction of N-Hydroxy-sulfonamides, Including N-Hydroxy-valdecoxib, by the Molybdenum-Containing Enzyme mARC (2010) (38)
- The N-oxidation of benzamidines in vitro. (1983) (35)
- Reduction of Amidoxime Derivatives to Pentamidine in vivo. (1992) (30)
- Hepatic microsomal N-hydroxylation of adenine to 6-N-hydroxylaminopurine. (1990) (30)
- Activation of the anti-cancer agent upamostat by the mARC enzyme system (2013) (28)
- Structure-activity relationship of novel and known inhibitors of human dimethylarginine dimethylaminohydrolase-1: alkenyl-amidines as new leads. (2008) (28)
- Diacetyldiamidoximeester of Pentamidine, a Prodrug for Treatment of Protozoal Diseases: Synthesis, in vitro and in vivo Biotransformation (2006) (27)
- Enzymatic Reduction of Benzamidoxime to Benzamidoxine (1988) (27)
- Crystal structure of human mARC1 reveals its exceptional position among eukaryotic molybdenum enzymes (2018) (25)
- Highly Potent and Selective Substrate Analogue Factor Xa Inhibitors Containing D‐Homophenylalanine Analogues as P3 Residue: Part 2 (2007) (23)
- Synthetic approaches to N(delta)-methylated L-arginine, N(omega)-hydroxy-L-arginine, L-citrulline, and N(delta)-cyano-L-ornithine. (2008) (22)
- Amidoximes of pentamidine: synthesis, trypanocidal and leishmanicidal activity. (1985) (22)
- Characteristics of the microsomal N-hydroxylation of benzamidine to benzamidoxime. (1987) (22)
- Zanamivir Amidoxime- and N-Hydroxyguanidine-Based Prodrug Approaches to Tackle Poor Oral Bioavailability. (2015) (21)
- Reduction of sulfamethoxazole hydroxylamine (SMX-HA) by the mitochondrial amidoxime reducing component (mARC). (2014) (21)
- The reduction of 6-N-hydroxylaminopurine to adenine by xanthine oxidase. (1992) (21)
- Cytochrome P450-dependent N-hydroxylation of an aminoguanidine (amidinohydrazone) and microsomal retroreduction of the N-hydroxylated product. (1994) (21)
- The N-Reductive System Composed of Mitochondrial Amidoxime Reducing Component (mARC), Cytochrome b5 (CYB5B) and Cytochrome b5 Reductase (CYB5R) Is Regulated by Fasting and High Fat Diet in Mice (2014) (20)
- The Mitochondrial Amidoxime Reducing Component (mARC): Involvement in Metabolic Reduction of N‐Oxides, Oximes and N‐Hydroxyamidinohydrazones (2014) (20)
- Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors. (2009) (19)
- Oxidation of desmethylpromethazine catalyzed by pig liver flavin-containing monooxygenase. Number and nature of metabolites. (1993) (18)
- Formation of guanoxabenz from guanabenz in human liver. A new metabolic marker for CYP1A2. (1997) (17)
- Analysis of highly potent amidine containing inhibitors of serine proteases and their N-hydroxylated prodrugs (amidoximes) (2011) (17)
- Reduction of amphetamine hydroxylamine and other aliphatic hydroxylamines by benzamidoxime reductase and human liver microsomes. (2000) (17)
- Oxygen-insensitive enzymatic reduction of oximes to imines. (2006) (17)
- New Prodrugs of the Antiprotozoal Drug Pentamidine (2011) (17)
- Hepatic microsomal N-demethylation of N-methylbenzamidine. N-dealkylation vs N-oxygenation of amidines. (1987) (16)
- The Pivotal Role of the Mitochondrial Amidoxime Reducing Component 2 in Protecting Human Cells against Apoptotic Effects of the Base Analog N6-Hydroxylaminopurine* (2015) (16)
- Synthesis and Characterization of para-Substituted N,N′-Dihydroxybenzamidines and Their Derivatives as Model Compounds for a Class of Prodrugs (2014) (16)
- Genotoxic activities of benzamidine and itsN-hydroxylated metabolite benzamidoxime inSalmonella typhimurium and mammalian cells (1988) (15)
- N,N'-dihydroxyamidines: a new prodrug principle to improve the oral bioavailability of amidines. (2007) (15)
- Detoxification of Trimethylamine N-Oxide by the Mitochondrial Amidoxime Reducing Component mARC. (2018) (15)
- MS³ fragmentation patterns of monomethylarginine species and the quantification of all methylarginine species in yeast using MRM³. (2013) (15)
- Biotransformations of Benzamidine and Benzamidoxime in vivo (1993) (14)
- Prodrug design for the potent cardiovascular agent Nω-hydroxy-L-arginine (NOHA): synthetic approaches and physicochemical characterization. (2011) (14)
- Characterization of biguanides by 15N NMR spectroscopy (1999) (14)
- A Dual Topoisomerase Inhibitor of Intense Pro‐Apoptotic and Antileukemic Nature for Cancer Treatment (2017) (13)
- Inhibition of purified and membrane-bound flavin-containing monooxygenase 1 by (N,N-dimethylamino)stilbene carboxylates. (1996) (13)
- Nδ-Methylated l-arginine derivatives and their effects on the nitric oxide generating system (2008) (13)
- Phase 2 metabolites of N-hydroxylated amidines (amidoximes): synthesis, in vitro formation by pig hepatocytes, and mutagenicity testing. (2001) (13)
- Synthesis and biological evaluation of L-valine-amidoximeesters as double prodrugs of amidines. (2011) (13)
- Synthesis and evaluation of pyrido[1,2-a]pyrimidines as inhibitors of nitric oxide synthases. (2009) (12)
- Mechanism of the microsomal N-hydroxylation of para-substituted benzamidines. (1988) (12)
- Metabolism of benzamidoxime (N-hydroxyamidine) in human hepatocytes and role of UDP-glucuronosyltransferases (2005) (12)
- Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes. (2005) (12)
- University education of medicinal chemists: comparison of eight countries. (2000) (11)
- New aspects of the microsomal N -hydroxylation of benzamidines (1991) (11)
- METABOLISM OF N-HYDROXYGUANIDINES (N-HYDROXYDEBRISOQUINE) IN HUMAN AND PORCINE HEPATOCYTES: REDUCTION AND FORMATION OF GLUCURONIDES (2005) (10)
- First detection and quantification of N(δ)-monomethylarginine, a structural isomer of N(G)-monomethylarginine, in humans using MS(3). (2016) (10)
- The Aza-Analogous Benzo[c]phenanthridine P8-D6 Acts as a Dual Topoisomerase I and II Poison, thus Exhibiting Potent Genotoxic Properties (2020) (10)
- Dimethylarginine‐Dimethylaminohydrolase‐2 (DDAH‐2) Does Not Metabolize Methylarginines (2012) (10)
- Microsomal formation of nitric oxide and cyanamides from non-physiological N-hydroxyguanidines: N-hydroxydebrisoquine as a model substrate. (1999) (10)
- Characterization of para‐substituted benzamidoximes and benzamidinium salts by 15N NMR spectroscopy (2002) (9)
- Mitochondrial amidoxime-reducing component 2 (MARC2) has a significant role in N-reductive activity and energy metabolism (2019) (9)
- New NO‐Donors with Antithrombotic and Vasodilating Activities, Part 17. Arylazoamidoximes and 3‐Arylazo‐1,2,4‐oxadiazol‐5‐ones (1997) (9)
- Efficient Synthesis of OpticallyPure Nω-Alkylated l-Arginines (2008) (9)
- The Peptidylglycine α‐Amidating Monooxygenase (PAM): A Novel Prodrug Strategy for Amidoximes and N‐Hydroxyguanidines? (2009) (9)
- Defining the Role of the NADH–Cytochrome-b5 Reductase 3 in the Mitochondrial Amidoxime Reducing Component Enzyme System (2016) (9)
- Functional Characterization of Protein Variants Encoded by Nonsynonymous Single Nucleotide Polymorphisms in MARC1 and MARC2 in Healthy Caucasians (2014) (9)
- Arginine methylation in yeast proteins during stationary-phase growth and heat shock (2015) (9)
- N-hydroxylation of benzamidine to benzamidoxime by a reconstituted cytochrome P-450 oxidase system from rabbit liver: involvement of cytochrome P-450 IIC3. (1993) (9)
- Reduction of Nω-hydroxy-l-arginine to l-arginine by pig liver microsomes, mitochondria, and human liver microsomes (2006) (9)
- Synthesis and physicochemical characterization of novel 6-aminopyrido[3,4-c][1,9]phenanthrolines as aza-analogs of benzo[c]phenanthridines (2012) (8)
- The Involvement of the Mitochondrial Amidoxime Reducing Component (mARC) in the Reductive Metabolism of Hydroxamic Acids (2018) (8)
- Designing modulators of dimethylarginine dimethylaminohydrolase (DDAH): A focus on selectivity over arginase (2012) (8)
- Metabolism of cytostatically active 6-aminobenzo[c]phenanthridines by human and porcine hepatic microsomes and recombinant cytochrome P450 enzymes (2006) (8)
- Metabolic N-hydroxylation of diminazene in vitro. (1992) (8)
- Electrochemical and mARC‐Catalyzed Enzymatic Reduction of para‐Substituted Benzamidoximes: Consequences for the Prodrug Concept “Amidoximes instead of Amidines” (2015) (7)
- Human mitochondrial amidoxime reducing component (mARC): An electrochemical method for identifying new substrates and inhibitors (2017) (7)
- Enzymatic Reduction of Benzamidoxime to Benzamidine. (1989) (7)
- Metabolism and distribution of two highly potent and selective peptidomimetic inhibitors of matriptase (2010) (6)
- Synthesis of 15Nω‐Hydroxy‐L‐arginine and ESR and 15N‐NMR Studies for the Elucidation of the Molecular Mechanism of Enzymic Nitric Oxide Formation from L‐Arginine (1994) (6)
- In vitro oxygenation of N,N'-diphenylguanidines. (1993) (6)
- Metabolism of promethazine in vitro. Identificaton of N-oxidized products. (1981) (6)
- A refined characterisation of the NeoHepatocyte phenotype necessitates a reappraisal of the transdifferentiation hypothesis. (2009) (6)
- Microsomal N‐Oxygenation of Adenine to Adenine 1‐N‐Oxide (1993) (6)
- Chapter 24 – Biotransformation Reactions and their Enzymes (2015) (6)
- Drug Metabolism by the Mitochondrial Amidoxime Reducing Component (mARC): Rapid Assay and Identification of New Substrates. (2019) (5)
- One-Step Synthetic Access to Isosteric and Potent Anticancer Nitrogen Heterocycles with the Benzo[c]phenanthridine Scaffold. (2016) (5)
- N-hydroxylation and N-dealkylation by P4502C3 of N-methylbenzamidine: N-oxygenation and N-oxidative dealkylation of one functional group. (1995) (5)
- Microsomal Catalyzed N‐Hydroxylation of Guanfacine and Reduction of N‐Hydroxyguanfacine (1997) (5)
- Inhibitory effects of cytostatically active 6-aminobenzo[c]phenanthridines on cytochrome P450 enzymes in human hepatic microsomes. (2006) (5)
- The Application of 15 N-NMR in the Analysis of N -Oxygenated amidines and guanidines (1991) (5)
- Synthesis of Some Metabolites of Promethazine (1981) (5)
- Letter to the editor: The clinically relevant MTARC1 p.Ala165Thr variant impacts neither the fold nor active site architecture of the human mARC1 protein (2022) (5)
- STRUCTURAL REQUIREMENTS OF MICROSOMAL N-OXYGENATIONS DERIVED FROM STUDIES ON AMIDINES (1989) (4)
- T4 lysozyme-facilitated crystallization of the human molybdenum cofactor-dependent enzyme mARC. (2018) (4)
- Inhibitory effects on cytochrome p450 enzymes of pentamidine and its amidoxime pro-drug. (2008) (4)
- Platform for determining the inhibition profile of neuraminidase inhibitors in an influenza virus N1 background. (2016) (4)
- 11‐Substituted Benzo[c]phenanthridines: New Structures and Insight into Their Mode of Antiproliferative Action (2016) (4)
- Involvement of stearoyl-CoA desaturase in the reduction of amidoxime prodrugs (2008) (4)
- Design, Synthesis, and Bioactivation of O-Glycosylated Prodrugs of the Natural Nitric Oxide Precursor N(ω)-Hydroxy-l-arginine. (2016) (4)
- N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system. (2008) (3)
- New NO-Donors with Antithrombotic and Vasodilating Activities. Part 17. Arylazoamidoximes and 3-Arylazo-1,2,4-oxadiazol-5-ones. (1998) (3)
- N‐Hydroxyisothioharnstoffe, 2. Mitt. Addition von N‐substituierten Hydroxylaminen an Methylthiocyanat (1988) (3)
- Synthesis, Characterization and NO Synthase Inhibition Testing of 2‐Aryl‐5‐aroyl‐3,4,5,6‐tetrahydropyrimidinium Chlorides (2015) (3)
- 1H, 13C and 15N NMR spectral analysis of substituted 1,2,3,4‐tetrahydro‐pyrido[1,2‐a]pyrimidines (2013) (3)
- Triggering the directional selectivity of a ring-closure reaction leads to pyridoazacarbazoles with anticancer properties. (2015) (3)
- High Antitumor Activity of the Dual Topoisomerase Inhibitor P8-D6 in Breast Cancer (2021) (3)
- Involvement of stearoyl-CoA desaturase in the reduction of amidoxime prodrugs. (2008) (3)
- Newly developed dual topoisomerase inhibitor P8-D6 is highly active in ovarian cancer (2021) (2)
- Reduction of Nomega-hydroxy-L-arginine to L-arginine by pig liver microsomes, mitochondria, and human liver microsomes. (2006) (2)
- A New Synthetic Approach to the Benzo[c]phenanthridine Ring System. (2005) (2)
- Synthesis of p-amino-N,N′-dihydroxybenzamidine using a TBDMS protecting group protocol (2014) (2)
- Active site architecture reveals coordination sphere flexibility and specificity determinants in a group of closely related molybdoenzymes (2021) (2)
- Arylazoamidoximes and Related Compounds as NO‐modulators (2010) (2)
- [Biotransformation processes in fertile hen's eggs. 1. Metabolic transformation of 7-ethoxycoumarin]. (1995) (2)
- Combined PARP and Dual Topoisomerase Inhibition Potentiates Genome Instability and Cell Death in Ovarian Cancer (2022) (2)
- An Efficient Synthesis of Optically Pure N δ-Monomethylated l-Arginine and l-Ornithine (2016) (1)
- Synthesis of Pyrido[3,4-c][1,9]phenanthroline – A Five-Step Procedure to a Novel N-Containing Ring Skeleton (2013) (1)
- A new synthetic approach to the benzo[c]phenanthridine ring system (2005) (1)
- Discovery of N-(4-Aminobutyl)-N'-(2-Methoxyethyl)guanidine as the First Selective, Non-Amino Acid, Catalytic Site Inhibitor of human dimethylarginine dimethylaminohydrolase-1 (hDDAH-1). (2019) (1)
- One‐Step Synthetic Access to Isosteric and Potent Anticancer Nitrogen Heterocycles with the Benzo[c]phenanthridine Scaffold. (2016) (1)
- Enzyme Electrode Biosensors for N-Hydroxylated Prodrugs Incorporating the Mitochondrial Amidoxime Reducing Component. (2022) (1)
- P216 genotoxic activities of N-hydroxylated derivatives of amidines, guanidines and amidinohydrazones in salmonella typhimurium (1994) (0)
- Amidines and guanidines and their derivatives for the treatment of diseases (2008) (0)
- Short communicationSC25 prediction of drug metabolism: N-oxygenation and retroreduction of the N-oxygenated metabolites (1994) (0)
- New insights into the mode of action of the antipsoriatic drug dimethylfumarate: P15 (2008) (0)
- Use of amidoximkarboxylsyreestre and N-hydroxyguanidin-karboxylsyreestre for the preparation of prodrugs (2009) (0)
- [Biotransformation of benzamidine and benzamidoxime by microsomal enzymes of the rabbit]. (1989) (0)
- Method for improved bioactivation of drugs (2009) (0)
- Studies of the N-Oxygenation of N-(tert-Alkyl)benzamidines in vitro. (1988) (0)
- Improve the bioavailability of drugs with amidine in drugs (2006) (0)
- [Biotransformation in hen's eggs. Metabolic transformation of p-nitrophenol]. (1996) (0)
- Synthesis of p‐Amino‐N,N′‐dihydroxybenzamidine Using a TBDMS Protecting Group Protocol. (2014) (0)
- Amidoxime esters carboxylic acids etexilate as prodrugs and their use as a medicine (2011) (0)
- Dabigatran amidoxinsyreestere as prodrugs, and their use as a medicament (2011) (0)
- Pentamidine amidoximsyreestere as prodrugs, and their use as a medicament. (2011) (0)
- pyrimidine substituted pyrido (1,2-a) and their use as NOS inhibitors (2004) (0)
- Full Paper Arylazoamidoximes and Related Compounds as NO- modulators (2010) (0)
- N‐Hydroxyisothioharnstoffe (0)
- Improving the bioavailability of active substances with amidinfunktion in drugs (2007) (0)
- Antitumor effect and potentiation of cytotoxic drug activity of a dual topoisomerase inhibitor on breast cancer (2019) (0)
- Improving the bioavailability of active substances with amidinfunktion in medications. (2007) (0)
- [In vitro studies on the microsomal N-oxidation of N-substituted benzamidines]. (1984) (0)
- Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients (2023) (0)
- N-Hydroxyisothioureas. Part 2. Addition of N-Substituted Hydroxylamines to Methyl Thiocyanate. (1989) (0)
- The mammalian molybdenum enzymes of mARC (2014) (0)
- Cover Picture: A Dual Topoisomerase Inhibitor of Intense Pro-Apoptotic and Antileukemic Nature for Cancer Treatment (ChemMedChem 5/2017) (2017) (0)
- The Novel Dual Topoisomerase Inhibitor P8-D6 Shows Anti-myeloma Activity In Vitro and In Vivo (2021) (0)
- ESTERS AND N-HYDROXYGUANDINE CARBOXYLIC ACID ESTERS FOR PRODUCING PRODRUGS (2017) (0)
- [In vitro studies of microsomal n-oxidation of various guanidines]. (1986) (0)
- Active Site Structures of the Escherichia coli N-Hydroxylaminopurine Resistance Molybdoenzyme YcbX. (2023) (0)
- The oral dosage form of dabigatran prodrugs to treat diseases (2016) (0)
- Improvement of the bioavailability of active ingredients with amidine function in medicines (2007) (0)
- Synthesis and Characterization of para‐Substituted N,N′‐Dihydroxybenzamidines and Their Derivatives as Model Compounds for a Class of Prodrugs. (2015) (0)
- Amino acid derivatives as drugs (2008) (0)
- A Novel Prodrug of a nNOS Inhibitor with Improved Pharmacokinetic Potential (2020) (0)
- In vivo SPECT imaging of [¹²³I]-labeled pentamidine pro-drugs for the treatment of human African trypanosomiasis, pharmacokinetics, and bioavailability studies in rats. (2014) (0)
- Hydroxyamidin- and hydroxyguanidinforbindelser as uroki-naseinhibitorer (2004) (0)
- Synthesis and Physicochemical Characterization of Novel 6-Aminopyrido[3,4-c][1,9]phenanthrolines as Aza-Analogues of Benzo[c]phenanthridines. (2013) (0)
- DMD055202 718..725 (2014) (0)
- Arginine methylation in yeast proteins during stationary-phase growth and heat shock (2015) (0)
- [The in vitro N-oxygenation of N-tert.alkyl-substituted benzamidine]. (1987) (0)
- Amidoxime esters using carboxylic acids and esters of N-carboxylic hidroxiguanidino for preparing prodrugs (2009) (0)
- [An important point of attach in AIDS treatment. HIV protease inhibitors: state of the art]. (2001) (0)
This paper list is powered by the following services:
Other Resources About Bernd Clement
What Schools Are Affiliated With Bernd Clement?
Bernd Clement is affiliated with the following schools:
